Tyrosine kinase inhibition produces specific alterations in axon guidance in the grasshopper embryo.
Tyrosine kinase signaling pathways are essential for process outgrowth and guidance during nervous system development. We have examined the roles of tyrosine kinase activity in programming growth cone guidance decisions in an intact nervous system in which neurons can be individually identified. We applied the tyrosine kinase inhibitors herbimycin A and genistein to whole 40% grasshopper embryos placed in medium, or injected the inhibitors into intact grasshopper eggs. Both inhibitors caused interneuronal axons that normally would grow along the longitudinal connectives to instead leave the central nervous system (CNS) within the segmental nerve root and grow out toward the body wall muscles. In addition, herbimycin A produced pathfinding errors in which many longitudinal axons crossed the CNS midline. To study how this drug affected guidance decisions made by individual growth cones, we dye-filled the pCC interneuron, which normally extends an axon anteriorly along the ipsilateral longitudinal connective. In the presence of herbimycin A, the pCC growth cone was redirected across the anterior commissure. These phenotypes suggest that tyrosine kinase inhibition blocks a signaling mechanism that repels the growth cones of longitudinal connective neurons and prevents them from crossing the midline.
Menon
K P
KP
Division of Biology, California Institute of Technology, Pasadena, CA 91125, USA.
Zinn
K
K
D000818:Animals; D001369:Axons / Q000187:drug effects / Q000502:physiology*; D016227:Benzoquinones; D002465:Cell Movement; D002490:Central Nervous System / Q000187:drug effects / Q000196:embryology; D046508:Culture Techniques; D004791:Enzyme Inhibitors / Q000494:pharmacology; D019833:Genistein / Q000494:pharmacology; D006110:Grasshoppers / Q000187:drug effects / Q000196:embryology*; D020439:Growth Cones / Q000187:drug effects / Q000502:physiology; D015151:Immunoblotting; D007150:Immunohistochemistry; D007395:Interneurons / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D047029:Lactams, Macrocyclic; D008854:Microscopy, Electron; D009046:Motor Neurons / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D009132:Muscles / Q000196:embryology; D009415:Nerve Net / Q000196:embryology; D010766:Phosphorylation; D019000:Phosphotyrosine / Q000032:analysis; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D011809:Quinones / Q000494:pharmacology; D017828:Rifabutin / Q000031:analogs & derivatives; D015398:Signal Transduction
D016227:Benzoquinones; D004791:Enzyme Inhibitors; D047029:Lactams, Macrocyclic; D011809:Quinones; D017828:Rifabutin; D019000:Phosphotyrosine; C020754:herbimycin; D019833:Genistein; D011505:Protein-Tyrosine Kinases